Position in OGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$385,240
+$201,072 QoQ
Shares Held
28,452
-7.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#202
of 625 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Range Financial Group LLC holds $24,424,846 across 12 Drug Manufacturers - General names. OGN ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,427 | $6,509,307 | |
| 2 | JNJ |
Johnson & Johnson
|
20,421 | $5,186,321 | |
| 3 | AMGN |
Amgen Inc
|
13,553 | $4,907,812 | |
| 4 | NVO |
Novo Nordisk A S
|
54,505 | $2,612,969 | |
| 5 | ABBV |
AbbVie Inc.
|
5,435 | $1,367,663 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,837 | $912,527 | |
| 7 | GSK |
GSK plc
|
16,868 | $884,220 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,073 | $523,380 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $385,240 | 28,452 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $184,168 | 30,746 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $186,269 | 25,979 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $299,979 | 28,088 | Shares | Sole | 2025-10-17 | |
| 2024-12-31 | $827,090 | 55,435 | Shares | Sole | 2025-01-07 | |
| 2024-06-30 | $836,963 | 40,433 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $739,874 | 39,355 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $165,757 | 11,495 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||